<?xml version="1.0"?>
<Articles JournalTitle="Immunology and Genetics Journal">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Immunology and Genetics Journal</JournalTitle>
      <Issn>2645-4831</Issn>
      <Volume>2</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="epublish">
        <Year>2019</Year>
        <Month>12</Month>
        <Day>01</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Gastrointestinal Manifestations in Patients with Common Variable Immunodeficiency</title>
    <FirstPage>185</FirstPage>
    <LastPage>195</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Kawthar Jasim</FirstName>
        <LastName>Mohammad Rida Al-Hussieni</LastName>
        <affiliation locale="en_US">Student Research Committee, Alborz University of Medical Sciences, Karaj, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Seyed Erfan</FirstName>
        <LastName>Rasouli</LastName>
        <affiliation locale="en_US">Student Research Committee, Alborz University of Medical Sciences, Karaj, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Gholamreza</FirstName>
        <LastName>Azizi</LastName>
        <affiliation locale="en_US">Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mehdi</FirstName>
        <LastName>Mosavian</LastName>
        <affiliation locale="en_US">Department of Gastroenterology and Hepatology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Rahman</FirstName>
        <LastName>Matani</LastName>
        <affiliation locale="en_US">Department of Gastroenterology and Hepatology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Kumars</FirstName>
        <LastName>Porrostami</LastName>
        <affiliation locale="en_US">Department of Pediatrics, Shahid Bahonar Hospital, Alborz University of Medical Sciences, Karaj, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mostafa</FirstName>
        <LastName>Qorbani</LastName>
        <affiliation locale="en_US">Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Marzieh</FirstName>
        <LastName>Tavakol</LastName>
        <affiliation locale="en_US">Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2019</Year>
        <Month>10</Month>
        <Day>19</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background/objectives:&#xA0; Common variable immunodeficiency (CVID) is one of the most prevalent symptomatic primary immunodeficiencies (PIDs), which manifest a wide clinical variability such as gastrointestinal (GI) disorder.
Methods: A total of 240 patients with CVID were enrolled in this study. The patients were evaluated for demographic data, clinical manifestations, and immunologic profile.
Results: In demographic data, the frequency of consanguinity and mortality rate were higher in patients with GI manifestation than those without GI manifestation. History of GI manifestations was evident in 147 patients (61.3%). The most common GI manifestation in patients with CVID was chronic diarrhea (29.6%). The prevalence of GI disease was 59 of 102 (57.8%) in female patients and 88 of 138 (63.8%) in male patients. The frequency of recurrent infection was higher in patients with GI manifestation than in those without GI manifestation. Also, CVID patients with GI manifestations had lower WBC and CD4+ T cells than patients without GI manifestations.
Conclusion: CVID patients are at increased risk of infectious conditions in the GI tract; hence GI manifestations are one of the most important presentations in CVID patients which can appear as a first manifestation or appear during the course of disease.</abstract>
    <web_url>https://igj.tums.ac.ir/index.php/igj/article/view/37</web_url>
    <pdf_url>https://igj.tums.ac.ir/index.php/igj/article/download/37/28</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Immunology and Genetics Journal</JournalTitle>
      <Issn>2645-4831</Issn>
      <Volume>2</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="epublish">
        <Year>2019</Year>
        <Month>12</Month>
        <Day>01</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Precision Medicine as Treatment for Primary Immunodeficiency and Immune Dysregulation</title>
    <FirstPage>153</FirstPage>
    <LastPage>172</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Rodrigo</FirstName>
        <LastName>Hoyos-Bachiloglu</LastName>
        <affiliation locale="en_US">Department of Pediatric Infectious Diseases and Immunology, Pontificia Universidad Catlica de Chile</affiliation>
      </Author>
      <Author>
        <FirstName>Craig</FirstName>
        <LastName>Platt</LastName>
        <affiliation locale="en_US">Division of Immunology, Boston Children&amp;rsquo;s Hospital, Harvard Medical School</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2019</Year>
        <Month>10</Month>
        <Day>19</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">&#x201C;Precision medicine&#x201D; is the use of therapy that targets the molecular basis of a patient&#x2019;s disease process. This approach is increasingly well-established in treatment of monogenic disorders of immunity, including primary immunodeficiencies and primary immune regulatory disorders. This is due to the exquisite detail with which many immune pathways have been defined, and the wide variety of immune modulatory medications that target these pathways. Here we review many of the most effective uses of this approach and suggest a framework for classifying these strategies.</abstract>
    <web_url>https://igj.tums.ac.ir/index.php/igj/article/view/35</web_url>
    <pdf_url>https://igj.tums.ac.ir/index.php/igj/article/download/35/26</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Immunology and Genetics Journal</JournalTitle>
      <Issn>2645-4831</Issn>
      <Volume>2</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="epublish">
        <Year>2019</Year>
        <Month>12</Month>
        <Day>01</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">NFKB2 Mutation in a Patient with Lymphopenia and Extreme Cold Sensitivity (a case report)</title>
    <FirstPage>207</FirstPage>
    <LastPage>212</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Arezou</FirstName>
        <LastName>Rezaei</LastName>
        <affiliation locale="en_US">Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Childrens Medical Center, Tehran University of Medical Science, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Paniz</FirstName>
        <LastName>Shirmast</LastName>
        <affiliation locale="en_US">Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Childrens Medical Center, Tehran University of Medical Science, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Hossein</FirstName>
        <LastName>Eslamian</LastName>
        <affiliation locale="en_US">Allergy and clinical immunology division, Department of pediatrics, Hamadan University of medical science, Hamadan, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2019</Year>
        <Month>10</Month>
        <Day>19</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">NF-&#x3BA;B pathway is a complex protein playing an important role in regulating lymphocyte development, immune responses, inflammation, cell proliferation, and cell death. The NF-kB signaling pathway has been described to be associated with canonical and noncanonical pathway. The canonical pathway utilizes NF-kB1, whereas the latter pathway involves NF-kB2, which is the cornerstone of the non-canonical NF-kB pathway, and has been shown to be critical for the development of secondary lymphoid organs, B cell development, and the humoral response to T-dependent and T-independent antigens. In this study, we investigated the patient with chief complain of low body temperature as well as feeling cold even in the warm seasons since 15 years ago. We reported a middle age man with mild lymphopenia and no significant infection, but hypothermia with significant chills even in the warm seasons with a mutation in NF-&#x3BA;B2 pathway.</abstract>
    <web_url>https://igj.tums.ac.ir/index.php/igj/article/view/39</web_url>
    <pdf_url>https://igj.tums.ac.ir/index.php/igj/article/download/39/30</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Immunology and Genetics Journal</JournalTitle>
      <Issn>2645-4831</Issn>
      <Volume>2</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="epublish">
        <Year>2019</Year>
        <Month>12</Month>
        <Day>01</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Autoimmunity in Patients with Hyper IgM Syndrome</title>
    <FirstPage>196</FirstPage>
    <LastPage>206</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Samaneh</FirstName>
        <LastName>Delavari</LastName>
        <affiliation locale="en_US">Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Tannaz</FirstName>
        <LastName>Moeini Shad</LastName>
        <affiliation locale="en_US">Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Childrens Medical Center, Tehran University of Medical Science, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Salar</FirstName>
        <LastName>Pashangzadeh</LastName>
        <affiliation locale="en_US">Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children&amp;rsquo;s Medical Center, Tehran University of Medical Science, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2019</Year>
        <Month>10</Month>
        <Day>19</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background/objectives: hyper-IgM (HIGM) syndrome is characterized by normal to increased serum IgM and very low or undetectable IgG, IgA, and IgE. HIGM (also known as class-switch recombination (CSR) defects) patients manifest different clinical manifestations such as autoimmune disorders. Aim of present study was to evaluate demographic data, clinical manifestation and immunological findings in HIGM patients. 
Methods: Clinical features and immunological data were collected from the 79 Iranian HIGM patients&#x2019; medical records diagnosed in Children&#x2019;s Medical Center in Iran. To compare clinical records and laboratory data, all HIGM patients were classified into two different groups patients with autoimmune disease and patients without autoimmune diseases.
Results: A total of 79 patients (60 male and 19 female ) with median (IQR) age at the time of the study of 12 (6-22.45). Autoimmunity diseases were seen in 19 patients (23.75% , 3 females and 16 males). Among the noninfectious manifestations, the hepatomegaly and spelenomegaly were significantly higher in patients with autoimmunity (p= 0.006) than patients without autoimmunity (p=0.006). The most common autoimmune presentations among HIGM patients were ITP (32%), juvenile rheumatoid arthritis (16%), autoimmune hemolytic anemia (11%) and Sclerosing cholangitis (11%), Gullain-Barr&#xE9; syndrome, Evans syndrome, diabetes mellitus and chrohn's disease. 
Conclusions: The relation between HIGM syndrome and autoimmunity disorders could lead to sever clinical complications. So, we suggested that immunologists to be aware of this complications.</abstract>
    <web_url>https://igj.tums.ac.ir/index.php/igj/article/view/38</web_url>
    <pdf_url>https://igj.tums.ac.ir/index.php/igj/article/download/38/27</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Immunology and Genetics Journal</JournalTitle>
      <Issn>2645-4831</Issn>
      <Volume>2</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="epublish">
        <Year>2019</Year>
        <Month>12</Month>
        <Day>01</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Why Should TREC and KREC Quantification Assay be Concerned about Screen of Newborns in Developing Countries?</title>
    <FirstPage>173</FirstPage>
    <LastPage>184</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Amir</FirstName>
        <LastName>Ghasemi</LastName>
        <affiliation locale="en_US">Department of Microbiology and Immunology, Faculty of Medicine, Kashan University of Medical Sciences, Kashan, Iran; Department of Infectious Disease and Immunology, College of Veterinary Medicine, University of Florida, FL, USA.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2019</Year>
        <Month>10</Month>
        <Day>19</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Primary immunodeficiencies contain a set of several different diseases. Giving the fact that their clinical outcome ranges from mild to potentially life-threatening, detecting the patients with these diseases in the neonatal period is considered as the main goal of efforts that are currently being made. It has been reported that T-cell receptor excision circles (TRECs) and kappa-deleting recombination excision circles (KRECs) are circular DNA segments produced in T and B cells during their maturation in the thymus and bone marrow, respectively. Fortunately, excision circles can be reliably quantified using real-time quantitative PCR techniques.</abstract>
    <web_url>https://igj.tums.ac.ir/index.php/igj/article/view/36</web_url>
    <pdf_url>https://igj.tums.ac.ir/index.php/igj/article/download/36/25</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Immunology and Genetics Journal</JournalTitle>
      <Issn>2645-4831</Issn>
      <Volume>2</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="epublish">
        <Year>2019</Year>
        <Month>12</Month>
        <Day>01</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">First Case of X-linked Recessive Anhidrotic Ectodermal Dysplasia with Immunodeficiency from Iran with Unusual Aspergillus Infection</title>
    <FirstPage>213</FirstPage>
    <LastPage>220</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Tooba</FirstName>
        <LastName>Momen</LastName>
        <affiliation locale="en_US">Department of Allergy and Clinical Immunology, Isfahan University of Medical Sciences, Isfahan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Abdolvahab</FirstName>
        <LastName>Alborzi</LastName>
        <affiliation locale="en_US">Clinical Microbiology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Hossein</FirstName>
        <LastName>Eslamian</LastName>
        <affiliation locale="en_US">Allergy and clinical immunology division, Department of pediatrics, Hamadan University of medical science, Hamadan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Jean-Laurent</FirstName>
        <LastName>Casanova</LastName>
        <affiliation locale="en_US">St Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, NY, USA.</affiliation>
      </Author>
      <Author>
        <FirstName>Capucine</FirstName>
        <LastName>Picard</LastName>
        <affiliation locale="en_US">Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U980, Necker Medical School, Paris Descartes Uni-versity, Sorbonne Paris Cit&#xE9;, France. AND Study Center for Primary Immunodeficiencies, AP-HP, Necker EnfantsMalades Hospital, Paris, France</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2019</Year>
        <Month>10</Month>
        <Day>19</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">NEMO (NF-&#x3BA;B essential modulator) is a regulatory factor involved in signaling pathways of innate and adaptive immune system. Hypomorphic mutation of IKBKG gene on X chromosome leads to X-linked recessive anhidrotic ectodermal dysplasia with immunodeficiency. The affected boys presented developmental phenotype with hypotrichosis, hypohidrosis; hypodontia with conical incisors; and susceptibility to pyogenic bacteria, mycobacteria, and viruses. Most of them have impaired antibody response to polysaccharide antigens. Here, we presented the case report of 7 years old Iranian boy with NEMO-deficiency and unusual Aspergillus infection.</abstract>
    <web_url>https://igj.tums.ac.ir/index.php/igj/article/view/40</web_url>
    <pdf_url>https://igj.tums.ac.ir/index.php/igj/article/download/40/29</pdf_url>
  </Article>
</Articles>
